Bellicum

Bellicum focuses on discovering and developing cellular immunotherapies for cancer and orphan inherited blood disorders.

Business Model:

Revenue: $11.8M

Employees: 2-10

Detailed Bellicum Information

Geographic Data

Bellicum headquarters map

Address: 3730 Kirby Drive,

City: Houston

State: TX

Zip: 77098

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$25M

Raised Total:

$290M

Metrics

4,245,900Website Global Rank

2,750Website Monthly Traffic

Twitter Followers

Description

Bellicum focuses on discovering and developing cellular immunotherapies for cancer and orphan inherited blood disorders.

Contact Phone:
+12814543424

Contact Email:

Bellicum went public on 11/19/2014 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
11/19/2014

Ticker Symbol:
BLCM

Amount Raised:
$115M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2012 Series B 3 $20M AVG Ventures
Remeditex Ventures
James Brown
AVG Ventures
Remeditex Ventures
10/2010 Debt Financing $1.2M
1/2014 Series B 2 $14.7M Remeditex Ventures
AVG Ventures
10/2020 Post-IPO Equity $25M
8/2014 Series C 9 $55M RA Capital Management
Ridgeback Capital
Ridgeway Capital Partners
Sabby Capital
Aju IB Investment
Jennison Associates
Redmile Group
Perceptive Advisors
venBio Partners
RA Capital Management
Ridgeback Capital
Ridgeway Capital Partners
Sabby Capital
Aju IB Investment
Jennison Associates
Redmile Group
Perceptive Advisors
3/2017 Post-IPO Equity $69M
1/2015 Post-IPO Debt 1 - Hercules Capital
Hercules Capital
4/2018 Post-IPO Equity $69M
4/2020 Debt $2M U.S. Small Business Administration.
8/2014 Series C $94.4M Redmile Group
venBio Select
Ridgeback Capital Management
Jennison Associates LLC
Rand Capital
Perceptive Advisors, LLC
AJU IB Investment
RA Capital Management
AVG Ventures
Remeditex Ventures
10/2007 Grant 1 $1.4M Texas Wide Open for Business
Texas Wide Open for Business
12/2010 Convertible Note $3M
3/2009 Venture Round $500k
12/2014 IPO $139.7M
11/2011 Equity $19.6M Remeditex Ventures
11/2009 Series A $4.5M
10/2009 Debt Financing $1.3M
3/2012 Series B $34.4M Remeditex Ventures, LLC
11/2016 Grant 1 $17M Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas
3/2011 Grant $5.7M
10/2007 Seed Round $2.3M
1/2015 Post-IPO Debt 1 - Hercules Capital
Hercules Capital
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research